Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, National, Multicenter, Randomized, Double-blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 20 Association on the Dyslipidemia Treatment

NCT03540355 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT03540355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03540355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, National, Multicenter, Randomized, Double-blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 20 Association on the Dyslipidemia Treatment
Lead sponsor
EMS
Phase
Phase 3
Overall status
Completed
Start date
March 2, 2021
Completion date
January 23, 2025
Enrollment
406 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias